Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Mar. 31, 2013
Dec. 31, 2012
Current Assets    
Cash and cash equivalents $ 1,082,948 $ 2,197,555
Marketable securities 1,612,716 1,598,209
Restricted cash 554,092 553,682
Accounts receivable - project revenue and reimbursable project costs 418,113 601,803
Prepaid expenses & other current assets 706,369 574,590
Total Current Assets 4,374,238 5,525,839
Property Plant and Equipment -net 11,102 17,221
Other Assets    
Patent costs - net 634,953 600,596
Total Assets 5,020,293 6,143,656
Current Liabilities    
Accounts payable and accrued liabilities 393,619 385,223
Total Current Liabilities 393,619 385,223
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 500,000,000 authorized, 12,548,935 shares outstanding and 12,526,240 shares outstanding at March 31, 2013 and December 31, 2012, respectively 12,549 12,526
Additional paid in capital - stock and stock equivalents 72,105,896 71,955,631
Deficit (67,491,771) (66,212,849)
Common stock reserved for issuance, 2,264 shares at December 31, 2012 0 3,125
Total Stockholders' Equity 4,626,674 5,758,433
Total Liabilities and Stockholders' Equity $ 5,020,293 $ 6,143,656